Delivery Order SPE2DB22D3102-SPE2DB25FL2NG
- Not listed
- The Defense Logistics Agency awarded a $1,417.28 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Atropine 1 mg/10 ml syringes (10 ml quantity). This firm fixed price contract is scheduled for completion by July 30, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation, and the product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL syringes on August 19, 2025, with a ceiling value of $1,270.56 and an ultimate completion date of August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Atropine 1 mg/mL vials. This firm fixed price delivery order, valued at $1,339.21, represents a non-competitive award and is set to be completed by July 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Atropine 1 mg/10 mL syringes with a ceiling value of $1,681.81. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The product will be performed and delivered from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $2,111.43. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Atropine 1 mg/ml vials. This firm fixed-price delivery order, valued at $6,487.05, represents a non-competitive award with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Atropine 1 mg/ml vials. This firm fixed-price delivery order, valued at $4,324.70, is set to be completed by August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded without any set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Atropine 1 mg/mL vials valued at $3,459.76. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Atropine 1 mg/mL vials with a ceiling value of $1,435.74. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 13, 2025. The award represents a delivery order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,046.81 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Atropine 1 mg/mL vials. This is a firm fixed price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania location and an ultimate completion date of July 21, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2NGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Atropine 1 mg/10 mL syringes with a ceiling value of $1,044.75. This firm fixed-price delivery order, which concludes on August 13, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. The award was made without a set-aside designation through open competition, and performance will occur at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX prime contract vehicle enables AmerisourceBergen to supply comprehensive pharmaceutical products and medical supplies globally to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for atropine auto-injectors reflects the contractor's ongoing role as a pharmaceutical prime vendor delivering critical medical commodities across multiple therapeutic domains to federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/12/25 |